N/A
N=366
Undiagnosed Hepatitis C Infection in an Urban Hospital
Hepatitis C
Bottom Line
View on ClinicalTrials.gov: NCT01957085 ↗Enrolled (actual)
366
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Point Prevalence of Hepatitis C Infection — 9 percentage of total subjects
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- observation only (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Temple University
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Point Prevalence of Hepatitis C Infection |
9 | — |
Summary
The Centers for Disease Control and Prevention estimates that there are approximately 3.2 million people in the United States infected with hepatitis C and a significant percentage of these patients are unaware of their diagnosis. This study will attempt to determine the point prevalence of undiagnosed hepatitis C infection in an urban hospital population. All patients admitted to the hospital on two separate days will have hepatitis C testing done on leftover serum and plasma that was collected as part of routine inpatient lab work. Our primary goal is to determine the number of undiagnosed hepatitis C infected patients in our hospitalized population. We will also compare these rates to specific demographic characteristics, such as age, race, gender, zip code and type of insurance to see if any associations exist between these demographics and undiagnosed hepatitis C infection.
Eligibility Criteria
Inclusion Criteria
- Patient admitted to Temple University Hospital on either of the study dates
Exclusion Criteria
- Patients admitted on both study dates will only be counted once
Data sourced from ClinicalTrials.gov (NCT01957085). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.